Operational Update
Kenmare Resources plc (“Kenmare” or the “Company” or “the Group”) 2 March 2023 Operational Update Kenmare Resources
Globe Newswire2-03-2023, 14:03
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51